(Reuters) -The U.S. Food and Drug Administration said on Thursday it has awarded six more companies, including Eli Lilly and ...

Eli Lilly’s star oral GLP-1 candidate orforglipron and Novo Nordisk’s Wegovy (semaglutide) were named voucher winners in a ...

The FDA announced the second batch of companies being granted a “Commissioner’s National Priority Voucher,” a ticket to ...

George Tidmarsh left the agency amid accusations of misusing his authority and after clashing with another top official.

Dr. George Tidmarsh had been placed on leave Friday after Health and Human Services officials were notified of the issues, a ...

The head of the U.S. Food and Drug Administration’s drug division, Dr. George F. Tidmarsh, resigned on November 2, 2025, one ...

The FDA warning letters mostly went to cosmetic websites. In each case, the FDA said the companies were offering unofficial ...

Here’s what you need to know about the “mystery liquids” being sold to cost-cutters and unqualified injectors.

The U.S. FDA approved a pricey rare disease drug in September despite findings by its data reviewers that the treatment, ...

After a three-month delay, the FDA has now rejected an approval request based on the RWE. According to Biohaven, the FDA’s complete response letter “cited issues that can be inherent to real-world ...

Senate Democrats warned the Trump administration against imposing additional restrictions on access to abortion pills in ...

The top drug regulator at the Food and Drug Administration (FDA) resigned Sunday, according to officials, after being accused ...